EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Culture-Free Lipidomics-Based Screening Test for Uropathogens

Linda K Nartey iD, Mert Pekcan, Jun Liu, Victor Yuen, Pamela Kibsey, Robert K Ernst, David R Goodlett, Michael X Chen

Clinical Chemistry · 05.03.2026 · 72 (3) · 381-389

DOI: 10.1093/clinchem/hvaf164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Chemistry, online erschienen am 05.12.2025. Verfasst von Linda K Nartey und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada. Hauptthemen laut MEDLINE: Urinary Tract Infections, Lipidomics, Gram-Positive Bacteria, Gram-Negative Bacteria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Victoria Hospitals Foundation Catalyst, Technological Research Council of Turkey.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A rapid culture-free method is needed to improve diagnostic efficiency and guide timely antimicrobial therapy for urinary tract infections (UTIs). Previously, we utilized the lipidomics-based fast lipid analysis technique (FLAT) to screen for uropathogens by identifying distinctive microbial membrane lipid profiles, specifically lipid A in gram-negative and cardiolipin in gram-positive bacteria. This culture-free assay demonstrated high sensitivity (94%) in detecting gram-negative bacteria but poor sensitivity (51%) for gram-positive bacteria.

Methods

In this study, we pretreated urine pellets with lysozyme prior to FLAT analysis to break down the peptidoglycan layer bacteria, thereby promoting the efficient release of cardiolipin. The limit of detection (LOD) for 4 gram-positive bacteria and Escherichia coli was evaluated using contrived samples with known CFU/mL values and varying concentrations of lysozyme. Subsequently, we validated the optimized method in a clinical cohort of 76 urine samples known to contain gram-positive bacteria as confirmed by urine culture.

Results

Optimal sensitivity was achieved by treating 1 mL of urine pellets with 100 µg lysozyme and incubating for 60 minutes, resulting in a 100-fold increase in cardiolipin LOD and a 95% detection rate for gram-positive bacteria. Signal-to-noise ratio for lipid A was also improved. Polymicrobial urine cultures with gram-negative and gram-positive species were identified in 2 patients.

Conclusions

The lysozyme-enhanced FLAT assay enables rapid and culture-free detection of both gram-negative and gram-positive uropathogens directly from urine. The unified workflow decreases the analytical turnaround time by at least 90% making it well-suited for high-throughput clinical laboratories.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Tract InfectionsLipidomicsGram-Positive BacteriaGram-Negative BacteriaHumansEscherichia coliMuramidaseLimit of DetectionCardiolipins

Substanzen

MuramidaseCardiolipins

Autor:innen und Institutionen

  • Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada.
  • Genome British Columbia Proteomics Centre, University of Victoria, Victoria, BC, Canada.
  • Faculty of Veterinary Medicine, Department of Biochemistry, Ankara University, Ankara, Turkey.
  • Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Department of Pathology, Laboratory Medicine & Medical Genetics, Vancouver Island Health Authority, Victoria, BC, Canada.
  • Department of Microbial Pathogenesis, University of Maryland, Baltimore, MD, United States.

ORCID-Profile: Linda K Nartey

Förderung

  • NIH HHS
  • Victoria Hospitals Foundation Catalyst
  • Technological Research Council of Turkey
  • International Postdoctoral Research Fellowship Program
  • National Institutes of Health

Zitieren

APA

Nartey, L. K., Pekcan, M., Liu, J., Yuen, V., Kibsey, P., Ernst, R. K., Goodlett, D. R., & Chen, M. X. (2026). A Culture-Free Lipidomics-Based Screening Test for Uropathogens. Clinical Chemistry, 72(3), 381-389. https://doi.org/10.1093/clinchem/hvaf164

Vancouver

Nartey LK, Pekcan M, Liu J, Yuen V, Kibsey P, Ernst RK, et al. A Culture-Free Lipidomics-Based Screening Test for Uropathogens. Clinical Chemistry. 2026;72(3):381-389. doi:10.1093/clinchem/hvaf164

BibTeX
@article{Nartey2026,
  author = {Nartey, Linda K and Pekcan, Mert and Liu, Jun and Yuen, Victor and Kibsey, Pamela and Ernst, Robert K and Goodlett, David R and Chen, Michael X},
  title = {A Culture-Free Lipidomics-Based Screening Test for Uropathogens},
  journal = {Clinical Chemistry},
  year = {2026},
  volume = {72},
  number = {3},
  pages = {381--389},
  doi = {10.1093/clinchem/hvaf164}
}
Kostenlos starten →